Cantex Pharmaceuticals Competitors and Similar CompaniesClear all
Cantex Pharmaceuticals's competitors and similar companies include Nektar Therapeutics and Nykode Therapeutics.
 Cantex Pharmaceuticals Cantex Pharmaceuticals is a pharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancer. |  Nykode Therapeutics Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies. | ||
Founding Date | Founding Date 2002 | Founding Date 1990 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Weston, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Oslo, NO HQ |
Employees | Employees 650% increase | Employees 61821% increase | Employees 135 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 144.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income ($12.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 27.4m | Total funding raised $ 45m | Total funding raised $ 31.5m |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyNykode Therapeutics
HQ
Oslo, NO
Employees
135
Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies.
View company